10967/276 - QDB Compounds

QsarDB Repository

Zukic, S.; Ivanova, L.; Zusinaite, E.; Merits, A.; Maran, U. Discovery of a Novel Phthalazine-Based VEGFR-2 Inhibitor by Machine Learning Analysis of Diverse Chemical Space with Favorable Pharmacophores and Its Evaluation in Glioblastoma Cell Lines. Results in Chemistry, Under revision

Compound

ID:148
Name:Compound 148
Description:Original numeration in publication: 7e
Labels:Training_set, Phthalazines
CAS:
InChi Code:InChI=1S/C26H26N6OS/c1-2-3-17-27-26(34)32-31-25(33)19-13-15-20(16-14-19)28-24-22-12-8-7-11-21(22)23(29-30-24)18-9-5-4-6-10-18/h4-16H,2-3,17H2,1H3,(H,28,30)(H,31,33)(H2,27,32,34)

Properties

pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]

ValueSource or prediction
7

El-Adl, K.; Ibrahim, M. K.; Khedr, F. a. A., H. S.; Eissa, I. H. Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2022, 355, e2100278. https://doi.org/10.1002/ardp.202100278

6.80238

Eq1: VEGFR-2 inhibition (Data used to train model)